» Articles » PMID: 7805038

Epstein-Barr Virus in Epithelial Cell Tumors: a Breast Cancer Study

Overview
Journal Cancer Res
Specialty Oncology
Date 1995 Jan 1
PMID 7805038
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The human herpes virus Epstein-Barr (EBV) is clearly associated with African Burkitt's lymphoma and the undifferentiated from of nasopharyngeal carcinoma, although its role in oncogenesis is still poorly defined. Recently EBV has been implicated in other types of lymphomas, as well as in some nonlymphomatous neoplastic processes. Its possible association with human breast cancer has been investigated here. DNA from 91 cases of breast carcinoma and blood samples from the same patients were amplified with the PCR over a region in the EBV BamHIW major repeat sequence following a single-step amplification protocol. Nineteen samples (21%) were found to be positive; 10 samples of blood (only 3 of them from patients with EBV-positive tumors) were found by the adopted protocol to contain EBV DNA. Another series of PCR amplifications using primers covering a unique (nonreiterated) fragment in BamHIC encoding the EBERs (two short nonpolyadenylated RNAs generally highly expressed in cells latently infected with EBV) confirmed these findings. A good correlation between the two sets of experiments was observed, and only five differences in results were obtained on samples tested. In situ hybridization was carried out using BamHIW biotinylated DNA probes or EBER-1 digoxigenin-labeled riboprobes with the aim of confirming as well as localizing the signal to the epithelial cell. Twelve sections (63%) among the PCR-positive samples were found positive by in situ hybridization with the DNA probe, and six (31.5%) sections were found with the RNA probe. Twenty-one samples from benign breast tumors or normal breast tissue were used as controls for PCR amplification in this study, none of which was found positive. This is the first known report showing positive results for EBV in breast cancer. No statistical association was found in these studies between the presence of EBV and the histological type of the tumor, however. Its role therefore remains for the moment unknown, as well as does the significance of the association of EBV with only a subset of the cases.

Citing Articles

The viral origins of breast cancer.

Lawson J, Glenn W Infect Agent Cancer. 2024; 19(1):39.

PMID: 39187871 PMC: 11346025. DOI: 10.1186/s13027-024-00595-2.


Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis.

Hsu Y, Tsai M, Wu G, Liu C, Chang Y, Lam H J Cancer. 2024; 15(8):2403-2411.

PMID: 38495506 PMC: 10937271. DOI: 10.7150/jca.93631.


Liquid Chromatography Tandem Mass Spectrometric Method for Quantification of Margetuximab in Rat Plasma and Application to a Pharmacokinetic Study.

Gaddey P, Sundararajan R AAPS PharmSciTech. 2024; 25(2):33.

PMID: 38332459 DOI: 10.1208/s12249-024-02755-4.


Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases.

Gutjahr E, Fremd C, Arnscheidt J, Penzel R, Wacker J, Sinn P Pathogens. 2023; 12(12).

PMID: 38133273 PMC: 10747629. DOI: 10.3390/pathogens12121387.


Epstein-Barr Viral Infection and the Risk for Breast Cancer: A Systematic Review.

Agolli A, Ishak A, Viswanathan M, Lorraine Co E, Shivakumar J, Agolli O Int J Hematol Oncol Stem Cell Res. 2023; 17(2):114-124.

PMID: 37637768 PMC: 10452945. DOI: 10.18502/ijhoscr.v17i2.12650.